Abstract:Objective:Nutritional complications is an important prognosis factor for continuous ambulatory peritoneal dialysis (CAPD) patients. In this study, we investigated the short term effects of intraperitoneal amino acid solution in CAPD patients for six months. Methodology:Twenty-four CAPD patients were enrolled in this study, and randomly divided into the treatment group and the control group(12 in each). In the treatment group, during the day-time exchange of dialysate, each patient recieved a bag of dialysate(1.5% Dianeal) enriched with 100ml branch-chain amino acid. The control group, patients continued their CAPD with the same dialysate(1.5% Dianeal) as usual. All the patients were followed-up in this study for six months. Serum levels of albumin, transferrin, prealbumin were determined monthly. Nutritional parameters as nPNA(the normalized protein equivalent of nitrogen appearance), %LMB(percentage of lean body mass), MAMC(middle-arm muscle circumference) and TSF(triceps skinfold)were assessed during the study. Results:In the treatment group, serum level of albumin increased significantly as compared with the baseline level[(38.67±6.81)g/L vs (42.44±3.60)g/L, P0.05] after three months of treatment. Serum levels of transferrin[(2.74±0.37)g/L vs (2.93±0.16)g/L, P0.05] and prealbumin [(461.38±330.29)g/L vs (641.57±673.91)g/L,P0.05] were also found increased after three months of treatment and being stable thereafter. While in the control group, serum levels of transferrin [baseline vs 6-month:(2.51±0.47)g/L vs (2.41±0.53)g/L] and prealbumin [baseline vs 6-month: (450.12±286.31)g/L vs (351.58±172.36)g/L] declined singnificantly. Nutritional parameters as nPNA?%LBM and MAMC were stable throughout the study in the treatment group, while reduced singificantly in the control group (nPNA: 0.9612±0.13 vs 0.9426±0.17, P0.05; %LBM: 0.6849±0.02 vs 0.6452±0.04,P0.05) after the study. No significant difference in adequcy parameters of dialysis were found during the study. Triglycerides [baseline vs 6-month: (1.58±0.95)mmol/L vs (2.17±0.78)mmol/L,P0.05] and total cholesterol [baseline vs 6-month: (5.78±2.10)mmol/L vs (6.12±1.05)mmol/L,P0.05] increased significantly in the control group, while in the treatment group triglycerides decreased at the end of study[(1.66±0.94)mmol/L vs (1.52±0.56)mmol/L,P0.05]. No side effect and discomfirt complains were found in any patient of the treatment group during the dwelling of the amino acid enriched dialysate. Conclusion:Administration of amino acid enriched dialysate (1.5% dextrose) is a safe maneuver and a effective means to improve nutritional status in CAPD patients.

Effect of Puerarin on Oxidative Stress in Continuous Ambulatory Peritoneal Dialysis Patients

Puerarin Ameliorates Oxidative Stress in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Effect of lipoic acid on oxidative stress, inflammation and nutritional status in peritoneal dialysis patients

Impacts of Tanshinone ⅡA on Oxidative Stress in Continuous Ambulatory Peritoneal Dialysis Patients

Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients

The Effect of Puerarin on the Oxidative Stress in Cultured Human Peri-toneal Mesothelial Cells

Puerarin protects the cultured human peritoneal mesothelial cells from the damage caused by peritoneal dialysate

Accumulation of Circulating Advanced Oxidation Protein Products is an Independent Risk Factor for Ischaemic Heart Disease in Maintenance Haemodialysis Patients

Effects of different dialyzers on oxidative stress for maintenance hemodialysis patients

Impact of tanshinone ⅡA on efficacy of peritoneal ultrafiltration in patients undergoing continuous ambulatory peritoneal dialysis

Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study.

Inhibition Effect of Puerarin on the Formation of Advanced Glycosylation End Products in Peritoneal Dialysis Solution in Vitro

Effects of Puerarin on Early Diabetic Nephropathy

Effect of Puerarin on Fibrinolytic Activity and Lipid Peroxide in Patients with Coronary Heart Disease

Analysis of influencing factors of advanced glycation end products peptides in serum in continuous ambulatory peritoneal dialysis non-diabetic patients

A Short Term Study of Nutritional Effect of Intraperitoneal Amino Acid in CAPD Patients

Effect of Oral N-Acetylcysteine Treatment on Plasma Inflammatory and Oxidative Stress Markers in Peritoneal Dialysis Patients: A Placebo-Controlled Study

The effect of puerarin on the damage of osteoblasts induced by hydrogen peroxide

Changes of the peripheral blood endothelial progenitor cells in peritoneal dialysis patients and its impact factors

Effect of peritoneal dialysis on inflammatory factors,nutritional index and renal function in patients with chronic renal failure

Puerarin Exerts the Protective Effect Against Chemical Induced Dysmetabolism in Rats.